Moderate riskFDA DrugClass II

Imprimis Tri-Moxi eye injection recalled for glass-like particles

Imprimis NJOF recalled Tri-Moxi+ eye injections because some batches contain glass-like particles. The affected batches (25JAN033A and 25JAN033B) expire in February 2026. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. If you have Tri-Moxi+ (NDC 71384-746-06) with lot numbers 25JAN033A or 25JAN033B, do not use it.
  2. Contact your eye doctor or pharmacy immediately.
  3. Ask your healthcare provider about safe alternatives for your treatment.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 3 products — see all of them.

Details

Units affected
314 boxes of 6,280 pre-filled syringes
Illnesses reported
None reported
Manufactured in
1705 Route 46 Ste 6B, Ledgewood, NJ, United States
Classification
Class II
Recall number
D-0251-2026

In the FDA's words

Description
Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06. Presence of particulate matter - Glass like particles. Lot: 25JAN033A, 25JAN033B, Expires: 02/12/2026. Distribution: U.S Nationwide Affected quantity: 314 boxes of 6,280 pre-filled syringes
Hazard
Presence of particulate matter - Glass like particles.

3 products in this recall

Imprimis Dexamethasone-Moxifloxacin and Tri-Moxi+ recalled for glass particles

Imprimis is recalling three prefilled eye injection products because they may contain glass-like particles. The products are Dexamethasone Moxifloxacin, Dexamethasone Moxifloxacin Ketorolac, and Tri-Moxi+, with 1,688 affected boxes shipped nationwide. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics

ParticulateDrugsSold nationwideMore from FDA Drug